No. 标题 发布时间 16 Wellmarker Bio Teams Up with an AI Firm ‘AZothBio’ to Accelerate the Development of Targeted Cancer Therapy 2019-10-11 15 [Interview(EDAILY)] Overcoming the Inefficacious Colon Cancer Drugs Through Biomarker based Treatments 2019-10-04 14 Dong-Hoon Jin, CEO of Wellmarker Bio Gives Speech about ‘Correlation between Biomarker and Anticancer Drug Development’ at the ‘KOREA BIO INV... 2019-09-05 13 [Interview(Maeil Business Newspaper)] Wellmarker Bio Develops Anticancer Treatment based on Gene Expression 2019-08-21 12 [Interview(Hankyung)] Wellmarker Bio Develops 5 First-in-Class Candidates that Could Improve the Drug's Efficacy 2019-07-11 11 KIRAMS and WMBIO Signs Licensing Agreement 2019-07-10 10 Wellmarker Bio Successfully Raises $18M in Series B Funding Round 2019-07-09 9 Wellmarker Bio and Cytogen Teams Up for Companion Diagnostics 2019-06-17 8 WMBIO Grabs Attention as One of the Most Promising Biotech Startups by “Startup Today” Media 2019-05-22 7 WMBIO once again Enters into an Agreement with KDDF to Acquire the On-going Follow-up Project of WM-S1 2019-03-15 1 2 3 4
